Marco Miglionico

Atorvastatin Pretreatment Improves Outcomes in Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Coronary Intervention

Giuseppe Patti, Vincenzo Pasceri, Marco Miglionico et al. · Journal of the American College of Cardiology · 2007 · 478 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +7

Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention

Giuseppe Patti, Massimo Chello, Vincenzo Pasceri et al. · Journal of the American College of Cardiology · 2006 · 122 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Pharmacology +9

Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody‐coated stent: A prospective single‐center registry in high‐risk patients

Marco Miglionico, Giuseppe Patti, Andrea D’Ambrosio et al. · Catheterization and Cardiovascular Interventions · 2008 · 86 citations

Early prediction of contrast-induced acute kidney injury by a "bedside" assessment of Neutrophil Gelatinase-Associated Lipocalin during elective percutaneous coronary interventions

Annunziata Nusca, Marco Miglionico, Claudio Proscia et al. · PLoS ONE · 2018 · 23 citations · Full text

Neutrophil Gelatinase-associated Lipocalin, Coronary Artery Disease, Acute Myocardial Infarction +21

Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy

Giuseppe Patti, Massimo Chello, Laura Gatto et al. · Journal of Cardiovascular Medicine · 2010 · 22 citations